Rivaroxaban-d4 - ≥95 atom% D,≥98% , CAS No.1132681-38-9

CAS: 1132681-38-9 Cat. No.: R379847 Summenformel: C19H14D4ClN3O5S Molekulargewicht: 439.91 PubChem CID: 25255944
Zu bestellen verfügbar
GRADE & PURITY ≥95 atom% D,≥98%
Synonyms
AKOS040736674 | 1132681-38-9 | BAY 59-7939-d4 | DTXSID60649494 | 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)(~2~H_4_)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide | HY-50903S | Rivaroxaban D4 | 5-chloro-N-[[(5S)-2-oxo-3-[2,3,5,6-tetrad
Storage
Store at 2-8°C
Shipped In
Wet ice
★
Size
Deutschland (EU)
USA*
Price
Qty
1mg
R379847-1mg
—
2 Auf Lager

459,81€

755,71€
Speichern 295,90 € (39.15%)
5mg
R379847-5mg
—
2 Auf Lager

1.532,34€

2.267,32€
Speichern 734,97 € (32.42%)
10mg
R379847-10mg
—
2 Auf Lager

2.809,65€

3.392,77€
Speichern 583,12 € (17.19%)
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥95 atom% D,≥98% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at 2-8°C Ships Wet ice Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 1 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Übersicht

Rivaroxaban-d4 is a novel labeled antithrombotic agent. A highly potent and selective, direct FXa inhibitor.
Rivaroxaban-d4is a potent and selective inhibitor of FXa

Specifications

Synonyme
AKOS040736674 | 1132681-38-9 | BAY 59-7939-d4 | DTXSID60649494 | 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)(~2~H_4_)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide | HY-50903S | Rivaroxaban D4 | 5-chloro-N-[[(5S)-2-oxo-3-[2,3,5,6-tetrad
Spezifikationen & Reinheit
≥95 atom% D,≥98%
Storage
Store at 2-8°C
Verschickt in
Wet ice
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Reinheit
≥95 atom% D,≥98%
Namen und Kennungen
Pubchem Sid508812520
Kanonisches LächelnC1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl
IUPAC Name5-chloro-N-[[(5S)-2-oxo-3-[2,3,5,6-tetradeuterio-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide
InChIKeyKGFYHTZWPPHNLQ-UJCPGTITSA-N
INCHI1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1/i1D,2D,3D,4D
Isomere SMILES [2H]C1=C(C(=C(C(=C1N2CCOCC2=O)[2H])[2H])N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl)[2H]
PubChem CID 25255944
Molekulargewicht 439.91

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
KlasseOxazinanes
SubclassMorpholines
Intermediate Tree Nodes Not available
Direct ParentPhenylmorpholines
Alternative Parents Thiophene carboxamides  2-heteroaryl carboxamides  2,5-disubstituted thiophenes  Oxazolidinones  Aryl chlorides  Benzene and substituted derivatives  Tertiary carboxylic acid amides  Heteroaromatic compounds  Carbamate esters  Secondary carboxylic acid amides  Lactams  Oxacyclic compounds  Azacyclic compounds  Dialkyl ethers  Carbonyl compounds  Hydrocarbon derivatives  Organic oxides  Organochlorides  Organonitrogen compounds  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Phenylmorpholine - 2-heteroaryl carboxamide - Thiophene carboxamide - Thiophene carboxylic acid or derivatives - 2,5-disubstituted thiophene - Aryl chloride - Aryl halide - Monocyclic benzene moiety - Oxazolidinone - Benzenoid - Carbamic acid ester - Thiophene - Heteroaromatic compound - Tertiary carboxylic acid amide - Oxazolidine - Secondary carboxylic acid amide - Carboxamide group - Lactam - Oxacycle - Azacycle - Carboxylic acid derivative - Dialkyl ether - Ether - Organic oxide - Organohalogen compound - Organochloride - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Carbonyl group - Organic nitrogen compound - Organic oxygen compound - Aromatic heteromonocyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as phenylmorpholines. These are aromatic compounds containing a morpholine ring and a benzene ring linked to each other through a CC or a CN bond.
External Descriptors Not available
3D-Struktur
Interaktives chemisches Strukturmodell





Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDatumArtikel
K2518073Certificate of AnalysisNov 28, 2025 R379847
K2507086Certificate of AnalysisNov 25, 2025 R379847
G2214579Certificate of AnalysisJun 29, 2022 R379847
G2214580Certificate of AnalysisJun 29, 2022 R379847
G2214598Certificate of AnalysisJun 29, 2022 R379847
Chemische und physikalische Eigenschaften
LöslichkeitChloroform and DMSO
Schmelzpunkt (°C)224-225° C
Molekulargewicht439.900 g/mol
XLogP32.500
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Exact Mass439.091 Da
Monoisotopic Mass439.091 Da
Topological Polar Surface Area116.000 Ų
Heavy Atom Count29
Formal Charge0
Complexity645.000
Isotope Atom Count4
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Citations of This Product
Referenzen
1. Yuchen Qu, Zhuan Yang, Wen Ma, Peng Xiao, Yani Gu, Jie Pan, Xinyun Zhang, Chen Zhao, Yunli Yu.  (2026)  Moxifloxacin-Mediated Downregulation of Intestinal P-Glycoprotein Alters the Pharmacokinetics of Dabigatran Etexilate: Mechanistic Insights in Rats and PBPK Model-Informed Dose Optimization.  Pharmaceutics,  18  (8): (1031).  [PMID:] [10.3390/pharmaceutics18081031]
Lösungsrechner
Bewertungen

Kundenbewertungen

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.